Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein

Neuropharmacology

Volumn 51, Issue 3, 2006, Pages 524-535

  Shi, Ju ^a   Damjanoska, Katerina J ^a   Zemaitaitis, Bozena W ^a   Garcia, Francisca ^a   Carrasco, Gonzalo ^a   Sullivan, Nicole R ^a   She, Yijin ^b   Young, Kathleen H ^b   Battaglia, George ^a   Van De Kar, Louis D ^a   Howland, David S ^b   Muma, Nancy A ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b PFIZER INC   (United States)

Author keywords

G 11 protein; G q protein; Phospholipase C; Regulators of G protein signaling; Serotonin 2A receptor

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KETANSERIN; MUTANT PROTEIN; OXYTOCIN; PHOSPHOLIPASE C; RGS PROTEIN; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; HORMONE; ISOTOPE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; FEMALE; FRONTAL CORTEX; MALE; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; BRAIN CORTEX; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; GENETICS; IN SITU HYBRIDIZATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN BINDING; RADIOASSAY; RADIOIMMUNOASSAY; SEXUAL DEVELOPMENT; WESTERN BLOTTING;

AMPHETAMINES; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, WESTERN; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HORMONES; IN SITU HYBRIDIZATION; ISOTOPES; KETANSERIN; MALE; MUTANT PROTEINS; PHOSPHOLIPASE C; PROTEIN BINDING; RADIOIMMUNOASSAY; RADIOLIGAND ASSAY; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RGS PROTEINS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 33747051984     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.04.012     Document Type: Article

References (32)

1. Alper R.H. Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Neuroendocrinology 51 (1990) 255-260
2. Anger T., Zhang W., and Mende U. Differential contribution of GTPase activation and effector antagonism to the inhibitory effect of RGS proteins on Gq-mediated signaling in vivo. J. Biol. Chem. 279 (2004) 3906-3915
3. 2A receptor function in male and female rat offspring. Synapse 35 (2000) 163-172
4. Berman D.M., Wilkie T.M., and Gilman A.G. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86 (1996) 445-452
5. Bradley P.B., Engel G., Feniuk W., Fozard J.R., Humphrey P.P., Middlemiss D.N., Mylecharane E.J., Richardson B.P., and Saxena P.R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25 (1986) 563-576
6. Caroni P. Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J. Neurosci. Methods 71 (1997) 3-9
7. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
8. Carrasco G.A., Damjanoska K.J., D'Souza D.N., Zhang Y., Garcia F., Battaglia G., Muma N.A., and Van de Kar L.D. Short-term cocaine treatment causes neuroadaptive changes in Galphaq and Galpha11 proteins in rats undergoing withdrawal. J. Pharmacol. Exp. Ther. 311 (2004) 349-355
9. Damjanoska K.J., Heidenreich B.A., Kindel G.H., D'Souza D.N., Zhang Y., Garcia F., Battaglia G., Wolf W.A., Van de Kar L.D., and Muma N.A. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus. J. Pharmacol. Exp. Ther. 309 (2004) 1043-1050
10. DiBello P.R., Garrison T.R., Apanovitch D.M., Hoffman G., Shuey D.J., Mason K., Cockett M.I., and Dohlman H.G. Selective uncoupling of RGS action by a single point mutation in the G protein alpha-subunit. J. Biol. Chem. 273 (1998) 5780-5784
11. Dohlman H.G., and Thorner J. RGS proteins and signaling by heterotrimeric G proteins. J. Biol. Chem. 272 (1997) 3871-3874
12. Ghavami A., Hunt R.A., Olsen M.A., Zhang J., Smith D.L., Kalgaonkar S., Rahman Z., and Young K.H. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity. Cell Signal 16 (2004) 711-721
13. Grauer S.M., Brennan J.A., Piesla M.J., Comery T.A., Williams K., Shukhina E.H., Young K.H., and Rosenzweig-Lipson S. Behavioral parallels between transgenic RGS-insensitive Gqalpha mutant (G188S) rats and those treated with lithium chloride. Soc. Neurosci. (2000) Abstr. 26, 959.2
14. Gray J.A., and Roth B.L. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists. Brain Res. Bull. 56 (2001) 441-451
15. Hollinger S., and Hepler J.R. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54 (2002) 527-559
16. Howland D.S., She Y., Kulik J., Culpepper C., DeGennaro L.J., Khawaja X., Rosenzweig-Lipson S., Marquis K.L., Dohlman H.G., Cockett M.I., and Young K.H. Transgenic expression of an RGS-resistant Gqalpha mutant (G188S) in rat brain. Soc. Neurosci. (2000) Abstr. 26, 239.1
17. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. 99 (2002) 1604-1609
18. Jeong S.W., and Ikeda S.R. Endogenous regulator of G-protein signaling proteins modify N-type calcium channel modulation in rat sympathetic neurons. J. Neurosci. 20 (2000) 4489-4496
19. Lan K.L., Sarvazyan N.A., Taussig R., Mackenzie R.G., DiBello P.R., Dohlman H.G., and Neubig R.R. A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteins. J. Biol. Chem. 273 (1998) 12794-12797
20. Li Q., Levy A.D., Cabrera T.M., Brownfield M.S., Battaglia G., and Van de Kar L.D. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats. Brain Res. 630 (1993) 148-156
21. Li Q., Muma N.A., Battaglia G., and Van de Kar L.D. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. J. Pharmacol. Exp. Ther. 282 (1997) 1581-1590
22. Li Q., Wichems C., Heils A., Van de Kar L.D., Lesch K.P., and Murphy D.L. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. J. Pharmacol. Exp. Ther. 291 (1999) 999-1007
23. Nierenberg A.A., Farabaugh A.H., Alpert J.E., Gordon J., Worthington J.J., Rosenbaum J.F., and Fava M. Timing of onset of antidepressant response with fluoxetine treatment. Am. J. Psychiatry 157 (2000) 1423-1428
24. Pazos A., Cortes R., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346 (1985) 231-249
25. Rosenzweig-Lipson S., Brandt M., Williams K., Shukhina E., Howland D.S., Young K.H., and Marquis K. Potentiation of 5-HT2C and 5-HT2A mediated effectis in transgenic RGS-insensitive Gq (G188S) mutant rats. Soc. Neurosci. (2000) Abstr. 26, 239.3
26. Roth B.L. Multiple serotonin receptors: clinical and experimental aspects. Ann. Clin. Psychiatry 6 (1994) 67-78
27. Takasaki J., Saito T., Taniguchi M., Kawasaki T., Moritani Y., Hayashi K., and Kobori M. A novel Galphaq/11-selective inhibitor. J. Biol. Chem. 279 (2004) 47438-47445
28. Van de Kar L.D., and Blair M.L. Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol. 20 (1999) 1-48
29. Van de Kar L.D., Javed A., Zhang Y., Serres F., Raap D.K., and Gray T.S. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J. Neurosci. 21 (2001) 3572-3579
30. Wolf W.A., and Schutz L.J. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis. J. Neurochem. 69 (1997) 1449-1458
31. Zhang Y., Damjanoska K.J., Carrasco G.A., Dudas B., D'Souza D.N., Tetzlaff J., Garcia F., Hanley N.R., Scripathirathan K., Petersen B.R., Gray T.S., Battaglia G., Muma N.A., and Van de Kar L.D. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J. Neurosci. 22 (2002) 9635-9642
32. Zhang Y., Gray T.S., D'Souza D.N., Carrasco G.A., Damjanoska K.J., Dudas B., Garcia F., Zainelli G.M., Sullivan Hanley N.R., Battaglia G., Muma N.A., and Van de Kar L.D. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo. J. Pharmacol. Exp. Ther. 310 (2004) 59-66